Nabiha Saklayen is the CEO and cofounder of Cellino, where she works to make personalized cell therapies accessible for all.
Why you should listen
Nabiha Saklayen's team is building the first closed-loop system to make custom cell therapies accessible to every human for diseases such as Parkinson's, diabetes and vision loss. She was selected as a "Pioneer" in MIT Tech Review's "35 Innovators under 35" list for her patented invention in cellular laser editing and was a 2019 Forbes "30 under 30" awardee for health care. She received her PhD in physics from Harvard University as a Howard Hughes Medical Institute International Fellow. She is also the inaugural Tory Burch Foundation Fellow in Genomics at the Innovative Genomics Institute led by Nobel Laureate Dr. Jennifer Doudna.
Saklayen's commitment to creating accessible therapies for all humans comes from her multicultural upbringing: she was born in Saudi Arabia to Bangladeshi parents and grew up in Germany and Sri Lanka. She is keen to drive the diversification of STEM leadership and launched an education program nationwide to inspire the next generation of diverse STEM leaders.
